Browsing Category

Top Industry News

7526 posts

AbbVie To Acquire Depression Drug from Gilgamesh for $1.2 Bn 
By

By
AbbVie and Gilgamesh Pharmaceuticals, a New York-based clinical-stage bio/pharmaceutical company developing new chemical entities for psychiatric diseases, have entered an agreement under which AbbVie will acquire Gilgamesh’s lead investigational candidate,…

Supplier News: Thermo Fisher, Cambrex, Delpharm & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Cambrex, Delpharm, Grand River Aseptic Manufacturing, Famar Group, and Symbiosis.   Chemicals/Chemical API Manufacturing * Cambrex Expands Peptide Mfg Facility Formulation Development/Drug…

Partnering News: Novartis, Roche & More 
By

By
A roundup of bio/pharmaceutical partnering news from Novartis/Arrowhead Pharmaceuticals and Roche/OMass Therapeutics.  * Novartis, Arrowhead Pharmaceuticals in $2.2-Bn Parkinson’s Disease Drug Pact* Roche, OMass in $420-M deal for IBD program …

J&J To Invest $2 Bn Over 10 Years at Fujifilm’s North Carolina Site 
By

By
Johnson & Johnson (J&J) has announced that it will increase its presence in North Carolina with a 160,000+ square-foot dedicated manufacturing facility at Fujifilm Biotechnologies’ new biopharmaceutical manufacturing site in…

CSL Announces Restructuring; To Cut 15% of Workforce; Spin Out Vaccine Unit 
By

By
CSL is taking a series of initiatives that will result in a net headcount reduction of up to 15% of its employee base and which includes changes to its R&D…

AbbVie Completes $2.1-Bn Acquisition of Capstan Therapeutics 
By

By
AbbVie has completed its $2.1-billion acquisition of Capstan Therapeutics, a clinical-stage biotechnology company. The deal was announced in June 2025.  Capstan’s lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP)…

Supplier News: Oxford Biomedical, Piramal & Upperton Pharma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Oxford Biomedical, Piramal Pharma Solutions, and Upperton Pharma Solutions.   Biologics Manufacturing * Oxford Biomedical Raises $125 M in Growth Strategy Formulation Development/Drug Product Manufacturing *…

Global Briefs: Novo Nordisk, Jazz & Kite 
By

By
A roundup of news from Regeneron Pharmaceuticals, Jazz Pharmaceuticals/Saniona, Kite/Interius BioTherapeutics, and Novo Nordisk/BioMed X. Highlights below.   Mfg News * FDA Moves Out Review Date for Regeneron’s Eye-Care Drug Over Mfg…

AbbVie Investing $195 M in US-Based API Mfg Expansion 
By

By
AbbVie has announced a $195-million investment in its North Chicago, Illinois, manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.   This expansion is part of AbbVie’s…

BioNTech in $740-M Settlement in US with CureVac, GSK over COVID mRNA Vaccine 
By

By
Pfizer and BioNTech, a Mainz, Germany-based bio/pharmaceutical company, have entered an agreement with GSK and CureVac, a Tubingen, Germany-based clinical-stage bio/pharmaceutical company specializing in mRNA cancer immunotherapies and vaccines, to…